drugset / Trial / NCT00996879
Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects
NaSingle-groupOpen-label
Summary
The purpose of this study is to assess the effect of BMS-791325 on the pharmacokinetics of the CYP3A4 Probe Midazolam.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beclabuvir | Small molecule | 300 mg | Oral |
| Subject | Midazolam | Small molecule | 5 mg | Oral |